Ignite Creation Date:
2025-12-24 @ 1:03 PM
Ignite Modification Date:
2026-06-01 @ 3:56 PM
Study NCT ID:
NCT05918861
Status:
RECRUITING
Last Update Posted:
2025-08-08
First Post:
2023-06-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Sponsor:
DalCor Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DAL-302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |